Semaglutide

Semaglutide is a synthetic peptide studied in in-vitro and preclinical research as a GLP-1 receptor agonist. Research reagent only — not for human consumption or medical use.

Key facts

Class: GLP-1 agonist
Target: GLP-1 receptor
Form: Lyophilised (powder)
Status: Research Use Only

Documented research areas

Incretin signallingGLP-1 agonismPreclinical models

See Semaglutide

Study library

All results on PubMed

GLP-1 Metabolism Incretin

The study list is temporarily unavailable.

Results retrieved live from PubMed (NCBI). Research literature only — no medical advice.

Research peptides — Research Use Only

Not for human consumption
Not for the diagnosis, treatment or prevention of any disease